Literature DB >> 22240481

Diverse functional properties of Wilson disease ATP7B variants.

Dominik Huster1, Angelika Kühne, Ashima Bhattacharjee, Lily Raines, Vanessa Jantsch, Johannes Noe, Wiebke Schirrmeister, Ines Sommerer, Osama Sabri, Frieder Berr, Joachim Mössner, Bruno Stieger, Karel Caca, Svetlana Lutsenko.   

Abstract

BACKGROUND & AIMS: Wilson disease is a severe disorder of copper metabolism caused by mutations in ATP7B, which encodes a copper-transporting adenosine triphosphatase. The disease presents with a variable phenotype that complicates the diagnostic process and treatment. Little is known about the mechanisms that contribute to the different phenotypes of the disease.
METHODS: We analyzed 28 variants of ATP7B from patients with Wilson disease that affected different functional domains; the gene products were expressed using the baculovirus expression system in Sf9 cells. Protein function was analyzed by measuring catalytic activity and copper ((64)Cu) transport into vesicles. We studied intracellular localization of variants of ATP7B that had measurable transport activities and were tagged with green fluorescent protein in mammalian cells using confocal laser scanning microscopy.
RESULTS: Properties of ATP7B variants with pathogenic amino-acid substitution varied greatly even if substitutions were in the same functional domain. Some variants had complete loss of catalytic and transport activity, whereas others lost transport activity but retained phosphor-intermediate formation or had partial losses of activity. In mammalian cells, transport-competent variants differed in stability and subcellular localization.
CONCLUSIONS: Variants in ATP7B associated with Wilson disease disrupt the protein's transport activity, result in its mislocalization, and reduce its stability. Single assays are insufficient to accurately predict the effects of ATP7B variants the function of its product and development of Wilson disease. These findings will contribute to our understanding of genotype-phenotype correlation and mechanisms of disease pathogenesis.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22240481      PMCID: PMC3461965          DOI: 10.1053/j.gastro.2011.12.048

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  The Wilson's disease gene and phenotypic diversity.

Authors:  S M Riordan; R Williams
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  The Bradford method for protein quantitation.

Authors:  N J Kruger
Journal:  Methods Mol Biol       Date:  1994

4.  A high-affinity, calmodulin-dependent Ca2+ pump in the basal-lateral plasma membranes of kidney cortex.

Authors:  P Gmaj; M Zurini; H Murer; E Carafoli
Journal:  Eur J Biochem       Date:  1983-10-17

5.  The Lys1010-Lys1325 fragment of the Wilson's disease protein binds nucleotides and interacts with the N-terminal domain of this protein in a copper-dependent manner.

Authors:  R Tsivkovskii; B C MacArthur; S Lutsenko
Journal:  J Biol Chem       Date:  2000-10-25       Impact factor: 5.157

6.  High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis.

Authors:  K Caca; P Ferenci; H J Kühn; C Polli; H Willgerodt; B Kunath; W Hermann; J Mössner; F Berr
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

7.  Functional properties of the copper-transporting ATPase ATP7B (the Wilson's disease protein) expressed in insect cells.

Authors:  Ruslan Tsivkovskii; John F Eisses; Jack H Kaplan; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

8.  Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.

Authors:  Dominik Huster; Michael Hoppert; Svetlana Lutsenko; Jan Zinke; Claudia Lehmann; Joachim Mössner; Frieder Berr; Karel Caca
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein.

Authors:  Dominik Huster; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

10.  Identification of novel mutations and the three most common mutations in the human ATP7B gene of Korean patients with Wilson disease.

Authors:  Han-Wook Yoo
Journal:  Genet Med       Date:  2002 Nov-Dec       Impact factor: 8.822

View more
  49 in total

Review 1.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

2.  ATP7B variant c.1934T > G p.Met645Arg causes Wilson disease by promoting exon 6 skipping.

Authors:  Daniele Merico; Carl Spickett; Matthew O'Hara; Boyko Kakaradov; Amit G Deshwar; Phil Fradkin; Shreshth Gandhi; Jiexin Gao; Solomon Grant; Ken Kron; Frank W Schmitges; Zvi Shalev; Mark Sun; Marta Verby; Matthew Cahill; James J Dowling; Johan Fransson; Erno Wienholds; Brendan J Frey
Journal:  NPJ Genom Med       Date:  2020-04-08       Impact factor: 8.617

3.  Establishment of hepatic and neural differentiation platforms of Wilson's disease specific induced pluripotent stem cells.

Authors:  Fei Yi; Jing Qu; Mo Li; Keiichiro Suzuki; Na Young Kim; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Protein Cell       Date:  2012-07-18       Impact factor: 14.870

Review 4.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

5.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

6.  Human copper transporter ATP7B (Wilson disease protein) forms stable dimers in vitro and in cells.

Authors:  Samuel Jayakanthan; Lelita T Braiterman; Nesrin M Hasan; Vinzenz M Unger; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2017-08-24       Impact factor: 5.157

Review 7.  [Wilson disease].

Authors:  D Huster
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

Review 8.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

9.  Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.

Authors:  Gursimran Chandhok; Judit Horvath; Annu Aggarwal; Mohit Bhatt; Andree Zibert; Hartmut Hj Schmidt
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

10.  Wilson Disease: Epigenetic effects of choline supplementation on phenotype and clinical course in a mouse model.

Authors:  Valentina Medici; Dorothy A Kieffer; Noreene M Shibata; Harpreet Chima; Kyoungmi Kim; Angela Canovas; Juan F Medrano; Alma D Islas-Trejo; Kusum K Kharbanda; Kristin Olson; Ruijun J Su; Mohammad S Islam; Raisa Syed; Carl L Keen; Amy Y Miller; John C Rutledge; Charles H Halsted; Janine M LaSalle
Journal:  Epigenetics       Date:  2016-09-09       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.